Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Beta Bionics Inc shares valued at $37,780 were sold by Lezack Adam on Oct 31 ’25. At $26.87 per share, Lezack Adam sold 1,406 shares. The insider’s holdings dropped to 9,841 shares worth approximately $0.25 million following the completion of this transaction.
Also, Palasis Maria sold 1,406 shares, netting a total of over 37,834 in proceeds. Following the sale of shares at $26.91 each, the insider now holds 9,841 shares.
Before that, ADAM LEZACK had added 2,812 shares to its account. In a trade valued at $75,305, the Director bought Beta Bionics Inc shares for $26.78 each.
Analysts at Goldman upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early October. As of June 16, 2025, Truist has initiated its “Buy” rating for BBNX. Earlier on June 12, 2025, Lake Street initiated its rating. Their recommendation was “a Buy” for BBNX stock.
Analyzing BBNX Stock Performance
On last trading session, Beta Bionics Inc [NASDAQ: BBNX] plunged -5.55% to $25.04. The stock’s lowest price that day was $24.33, but it reached a high of $26.63 in the same session. During the last five days, there has been a drop of approximately -6.50%.
Support And Resistance Levels for Beta Bionics Inc (BBNX)
According to the 24-hour chart, there is a support level at 24.04, which, if violated, would cause prices to drop to 23.03. In the upper region, resistance lies at 26.34. The next price resistance is at 27.63. RSI (Relative Strength Index) is 56.52 on the 14-day chart, showing neutral technical sentiment.
Is Beta Bionics Inc subject to short interest?
Stocks of Beta Bionics Inc saw a sharp rise in short interest on 2025-10-15 jumping by 0.29 million shares to 4.17 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 3.88 million shares. A jump of 6.88% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.51 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.51.
Which companies own the most shares of Beta Bionics Inc (BBNX)?
In terms of Beta Bionics Inc share price expectations, FactSet research, analysts set an average price target of 32 in the next 12 months, up nearly 20.71% from the previous closing price of $26.51. Analysts anticipate Beta Bionics Inc stock to reach 35 by 2025, with the lowest price target being 23. On May 30, 2025, Wolfe Research assigned a price target of “an Outperform” to the stock and initiated coverage with a $20.
